Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins

被引:46
|
作者
Seo, Ean-jeong [1 ]
Weibel, Stephanie [2 ]
Wehkamp, Jan [3 ]
Oelschlaeger, Tobias A. [1 ]
机构
[1] Univ Wurzburg, Inst Mol Infect Biol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Bioctr, Dept Biochem, D-97080 Wurzburg, Germany
[3] Robert Bosch Krankenhaus, Dr Margarete Fischer Bosch Inst Clin Pharmacol &, Stuttgart, Germany
关键词
Probiotic; Recombinant defensins; E. coli Nissle 1917; HBD2; HD5; Antimicrobial activity; Secretion; NONPATHOGENIC ESCHERICHIA-COLI; HIGH-LEVEL EXPRESSION; INTESTINAL EPITHELIAL-CELLS; BETA-DEFENSIN; CROHNS-DISEASE; ANTIMICROBIAL ACTIVITY; HUMAN BETA-DEFENSIN-2; ULCERATIVE-COLITIS; MAINTAINING REMISSION; PEPTIDE ANTIBIOTICS;
D O I
10.1016/j.ijmm.2012.05.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The probiotic Escherichia coli strain Nissle 1917 (EcN) is one of the few probiotics licensed as a medication in several countries. Best documented is its effectiveness in keeping patients suffering from ulcerative colitis (UC) in remission. This might be due to its ability to induce the production of human beta-defensin 2 (HBD2) in a flagellin-dependent way in intestinal epithelial cells. In contrast to ulcerative colitis, for Crohn's disease (CD) convincing evidence is lacking that EcN might be clinically effective, most likely due to the genetically based inability of sufficient defensin production in CD patients. As a first step in the development of an alternative approach for the treatment of CD patients, EcN strains were constructed which were able to produce human et-defensin 5 (HD5) or beta-defensin 2 (HBD2). For that purpose, codon-optimized defensin genes encoding either the proform with the signal sequence of human alpha-defensin 5 (HD5) or the gene encoding HBD2 with or without the signal sequence were cloned in an expression vector plasmid under the control of the T7 promoter. Synthesis of the encoded defensins was shown by Western blots after induction of expression and lysis of the recombinant EcN strains. Recombinant mature HBD2 with an N-terminal His-tag could be purified by Ni-column chromatography and showed antimicrobial activity against E. coli, Salmonella enterica serovar Typhimurium and Listeria monocytogenes. In a second approach, that part of the HBD2 gene which encodes mature HBD2 was fused with the yebF gene. The resulting fusion protein YebFMHBD2 was secreted from the encoding EcN mutant strain after induction of expression. Presence of YebFMHBD2 in the medium was not the result of leakage from the bacterial cells, as demonstrated in the spent culture supernatant by Western blots specific for beta-galactosidase and maltose-binding protein. The dialyzed and concentrated culture supernatant inhibited the growth of E. coli, S. enterica serovar Typhimurium and L. monocytogenes in radial diffusion assays as well as in liquid culture. This demonstrates EcN to be a suitable probiotic E. coli strain for the production of certain defensins. (C) 2012 Elsevier GmbH. All rights reserved.
引用
收藏
页码:276 / 287
页数:12
相关论文
共 50 条
  • [41] Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
    Kan, Anton
    Gelfat, Ilia
    Emani, Sivaram
    Praveschotinunt, Pichet
    Joshi, Neel S.
    ACS SYNTHETIC BIOLOGY, 2021, 10 (01): : 94 - 106
  • [42] Efficient markerless integration of genes in the chromosome of probiotic E. coli Nissle 1917 by bacterial conjugation
    Seco, Elena M.
    Angel Fernandez, Luis
    MICROBIAL BIOTECHNOLOGY, 2022, 15 (05): : 1374 - 1391
  • [43] E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
    Chavkin, Theodore A.
    Pham, Loc-Duyen
    Kostic, Aleksandar
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] E. coli Nissle 1917 inhibits EPEC infection by its adherence via FIC fimbria
    Kleta, S.
    Nordhoff, M.
    Tedin, K.
    Wieler, L. H.
    Oswald, S.
    Oelschlaeger, T.
    Bleiss, W.
    Holland, G.
    Schierack, P.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 297 : 54 - 54
  • [45] Rational Design and Characterization of Nitric Oxide Biosensors in E. coli Nissle 1917 and Mini SimCells
    Chen, Xiaoyu J.
    Wang, Baojun
    Thompson, Ian P.
    Huang, Wei E.
    ACS SYNTHETIC BIOLOGY, 2021, 10 (10): : 2566 - 2578
  • [46] Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
    Pichet Praveschotinunt
    Anna M. Duraj-Thatte
    Ilia Gelfat
    Franziska Bahl
    David B. Chou
    Neel S. Joshi
    Nature Communications, 10
  • [47] Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant Enterococcus in the intestinal tract
    Geldart, Kathryn G.
    Kommineni, Sushma
    Forbes, Madeline
    Hayward, Michael
    Dunny, Gary M.
    Salzman, Nita H.
    Kaznessis, Yiannis N.
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2018, 3 (03) : 197 - 208
  • [48] Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
    Sarunas Tumas
    Trine Sundebo Meldgaard
    Troels Holger Vaaben
    Sara Suarez Hernandez
    Annemette Tengstedt Rasmussen
    Ruben Vazquez-Uribe
    Sine Reker Hadrup
    Morten O. A. Sommer
    Scientific Reports, 13
  • [50] Identification and characterization of microRNAs involved in the mechanism of action of probiotic bacteria E. coli Nissle 1917
    Cichon, C.
    Sabharwal, H.
    Schmidt, M. A.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 : 96 - 97